What medication should be prescribed for an 80-year-old patient taking escitalopram 10 mg daily who continues to have depressed mood and unstable sleep?

Increase Escitalopram to 20 mg Daily and Add Low-Dose Eszopiclone 1 mg at Bedtime

For this 80-year-old patient with persistent depression and insomnia despite escitalopram 10 mg daily, I recommend first increasing escitalopram to 20 mg daily (after at least one week at current dose), and adding eszopiclone 1 mg at bedtime for the insomnia component. This dual approach addresses both the inadequately treated depression and the comorbid insomnia.

Rationale for Escitalopram Dose Increase

The current escitalopram dose of 10 mg may be subtherapeutic. The FDA label indicates that both 10 mg and 20 mg doses are effective for major depressive disorder, and dose increases to 20 mg should occur after a minimum of one week 1. While 10 mg is often recommended for elderly patients 1, this patient's persistent depressive symptoms (low mood, anhedonia, poor concentration, passive death wishes) with a PHQ-9 equivalent severity suggest inadequate response warranting dose optimization before switching agents.

Key consideration: The patient has been on the current regimen long enough (appears to be several months based on context) to assess response. Escitalopram typically requires 4-8 weeks for full therapeutic effect 2.

Adding Eszopiclone for Insomnia

For the sleep component, eszopiclone 1 mg at bedtime is the optimal choice for this elderly patient 3. Here's why:

• Age-appropriate dosing: Guidelines specifically recommend 1 mg for elderly or debilitated patients (maximum 2 mg) 3
• Sleep maintenance benefits: Eszopiclone addresses both sleep-onset and sleep-maintenance insomnia, which this patient experiences (trouble falling asleep + multiple nighttime awakenings) 3
• Evidence in elderly: Eszopiclone 1-2 mg has established safety and efficacy in elderly patients with chronic insomnia, reducing sleep latency, increasing total sleep time, and improving daytime functioning 4
• Synergistic effects: Eszopiclone combined with escitalopram has demonstrated superior outcomes for both sleep and anxiety/mood symptoms compared to escitalopram alone 5
• Safety profile: Better tolerated than benzodiazepines in elderly patients, with lower risk of cognitive impairment and falls 6

Why Not Other Options?

Trazodone (commonly used off-label): While guidelines mention trazodone as an option for comorbid depression and insomnia 3, the 2017 AASM guideline explicitly suggests NOT using trazodone for insomnia due to insufficient evidence 7. Additionally, recent data shows concerning safety signals in elderly patients 8.

Mirtazapine: Could address both depression and sleep, but causes significant weight gain 2 and sedation that may worsen daytime functioning. Reserve this for treatment failure with current approach.

Benzodiazepines (temazepam, lorazepam): Higher risk of falls, cognitive impairment, tolerance, and dependence in elderly patients 3, 6, 3. The guidelines caution that benefits are outweighed by risks in older adults 6.

Zolpidem: While effective, primarily targets sleep-onset insomnia 3. This patient has both onset and maintenance problems, making eszopiclone more appropriate. If used, dose would be 5 mg (not 10 mg) in elderly 3.

Implementation Algorithm

1. Week 0-1: Continue escitalopram 10 mg daily
2. Week 1: Increase escitalopram to 20 mg daily (taken in morning to avoid insomnia exacerbation)
3. Week 1: Add eszopiclone 1 mg at bedtime on empty stomach
4. Week 4-6: Reassess depression (PHQ-9) and sleep quality
   • If sleep improves but depression persists: Consider augmentation strategies
   • If depression improves but sleep remains poor: May increase eszopiclone to 2 mg (maximum for elderly)
   • If both improve: Continue current regimen

Critical Safety Monitoring

Falls risk: Both SSRIs and hypnotics increase fall risk in elderly 6. Assess home safety, ensure adequate lighting for nighttime bathroom trips, and counsel on taking eszopiclone only when able to get 7-8 hours sleep.

Cognitive monitoring: Watch for confusion, memory problems, or daytime sedation. Eszopiclone at 1 mg has minimal cognitive effects 4, but monitor closely.

Suicidal ideation: The patient has passive death wishes. Weekly contact initially is prudent, with clear safety planning. SSRIs carry black box warnings for suicidality, though risk is lower in elderly than younger adults 9.

Hyponatremia: SSRIs cause hyponatremia more frequently in elderly 1. Check sodium at baseline and if confusion develops.

Duration of Hypnotic Therapy

Eszopiclone has no short-term usage restriction unlike other hypnotics 3, and the 12-week trial in elderly showed sustained efficacy without tolerance 4. However, attempt to taper after 8-12 weeks once depression improves, as treating the underlying depression often resolves insomnia. Taper gradually (e.g., every other night for 1-2 weeks) to avoid rebound insomnia 3.

When to Reconsider This Approach

If no improvement after 6-8 weeks at escitalopram 20 mg plus eszopiclone, this represents treatment-resistant depression requiring:

• Switch to different antidepressant class (venlafaxine, mirtazapine, bupropion)
• Augmentation with aripiprazole or lithium
• Psychiatric consultation for complex management 10

The combination approach is superior to monotherapy for comorbid depression and insomnia 5, making this the evidence-based first-line strategy for this patient.